Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing long-term safety and efficacy study of irbesartan in hypertension
jRCT1080220722Phase 4
- Sponsor
- Sumitomo Pharma
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of irbesartan in hypertension (HTN), sponsored by Sumitomo Pharma.
02
Drugs
irbesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT1080220722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220722.